Sheharyar Raza: Examining Guideline Discordance in Evidence-Based Apheresis Recommendations
Sheharyar Raza, Transfusion Medicine Specialist and Data Scientist at University Health Network, shared a post on LinkedIn about a recent article he and his colleagues co-authored, adding:
“In evidence based medicine, ‘discordance’ is when recommendations don’t align with evidence, either in strength or direction
Co-authors Jeremy Jacobs, et al examined discordance in the American Society for Apheresis guidelines, widely used to justify which patients should get exchange transfusions. The thrust of our argument is that although some discordance is expected in clinical areas dealing with clinical areas where it is harder to perform large studies (e.g. rare diseases), each instance should be transparently acknowledged and justified to highlight knowledge gaps and uncertainty.”
Title: When Strong Recommendations Rest on Weak Evidence: Lessons From Therapeutic Apheresis Guidelines
Authors: Jeremy W. Jacobs, Garrett S. Booth, Brian D. Adkins, Victoria Costa, Sheharyar Raza, Yara A. Park, Joseph Yossi Schwartz, Evan M. Bloch
Read the Full Article on Journal of Clinical Apheresis
More posts featuring Sheharyar Raza on Hemostasis Today.
-
Sep 14, 2026, 11:16Zahra Ghasemi: Breaking the Freezer Barrier in Plasma Transfusion
-
Sep 14, 2026, 09:44Mohammad Salar Amoli: Thrombin The Master Regulator of Coagulation
-
Sep 14, 2026, 09:23Claire Harrison: HemaSphere Introduces New Patient Editor Role
-
Sep 14, 2026, 09:13Eirini Zorba: Plasmapheresis in Focus Understanding Its Role in Patient Care
-
Sep 14, 2026, 08:55Abdulrahman Al-Mashdali։ Immune Checkpoint Inhibitor Associated HLH
-
Sep 14, 2026, 07:54Islam Sadek: SOHO2026 Highlights Advances in Hematologic Malignancies
-
Sep 14, 2026, 07:45Flora Peyvandi: Building a More Equitable Future for Hemophilia Care
-
Sep 14, 2026, 07:37Joseph Pierre Aboumsallem: ET Treatment Enters a New Chapter
-
Sep 14, 2026, 07:29Eric Topol: Will AI Replace Clinicians?